Results 291 to 300 of about 6,463,095 (311)

The value of progression-free survival to patients with advanced-stage cancer

Nature Reviews Clinical Oncology, 2011
Lesley Fallowfield
exaly  

Influence of an independent review committee on assessment of response rate and progression-free survival in phase III clinical trials

Annals of Oncology, 2010
G R Pond, P A Tang, P A Tang
exaly  

Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer†

Annals of Oncology, 2016
Dennis Slamon, Stefan Michiels, S Paluch-Shimon   +2 more
exaly  

Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas.

Neuro-Oncology, 2008
Minesh Mehta, Howard A Fine, Lisa M DeAngelis   +2 more
exaly  

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

Lancet, The, 2004
Jean-Yves Blay, Ian Judson
exaly  

A systematic review evaluating the relationship between progression free survival and post progression survival in advanced ovarian cancer

Gynecologic Oncology, 2012
Jianhua Wu, Richard Lilford, Sudha Sundar   +2 more
exaly  

NEJ026 trial: progression-free survival benefit is not enough

The Lancet Oncology, 2019
openaire   +2 more sources

Osimertinib prolongs progression-free lung cancer survival after chemotherapy

Ca-A Cancer Journal for Clinicians
Mike Fillon
exaly  

Chronological Trends in Progression-Free, Overall, and Post-Progression Survival in First-Line Therapy for Advanced NSCLC

Journal of Thoracic Oncology, 2019
Marc Buyse, Jacek Rutkowski, Jacek Jassem   +2 more
exaly  

Immunotherapy combination shows longer progression-free survival than chemotherapy alone for patients with a rare type of metastatic colorectal cancer

Ca-A Cancer Journal for Clinicians
Carrie Printz
exaly